CFR /  Title 21  /  Part 20: Public Information

Section No.	Description
Section 20.1	Production of records by Food and Drug Administration employees
Section 20.2	Certification and authentication of Food and Drug Administration records
Section 20.3	Policy on disclosure of Food and Drug Administration records
Section 20.20	Uniform access to records
Section 20.21	Partial disclosure of records
Section 20.22	Request for existing records
Section 20.23	Preparation of new records
Section 20.24	Retroactive application of regulations
Section 20.25	Indexes of certain records
Section 20.26	Submission of records marked as confidential
Section 20.27	Food and Drug Administration determinations of confidentiality
Section 20.28	Prohibition on withdrawal of records from Food and Drug Administration files
Section 20.29	Food and Drug Administration Division of Freedom of Information
Section 20.30	Retention schedule of requests for Food and Drug Administration records
Section 20.31	Disclosure of Food and Drug Administration employee names
Section 20.32	Form or format of response
Section 20.33	Search for records
Section 20.34	Filing a request for records
Section 20.40	Time limitations
Section 20.41	Aggregation of certain requests
Section 20.42	Multitrack processing
Section 20.43	Expedited processing
Section 20.44	Fees to be charged
Section 20.45	Waiver or reduction of fees
Section 20.46	Situations in which confidentiality is uncertain
Section 20.47	Judicial review of proposed disclosure
Section 20.48	Denial of a request for records
Section 20.49	Nonspecific and overly burdensome requests
Section 20.50	Referral to primary source of records
Section 20.51	Availability of records at National Technical Information Service
Section 20.52	Use of private contractor for copying
Section 20.53	Request for review without copying
Section 20.54	Indexing trade secrets and confidential commercial or financial information
Section 20.55	Applicability of exemptions
Section 20.60	Trade secrets and commercial or financial information which is privileged or confidential
Section 20.61	Inter- or intra-agency memoranda or letters
Section 20.62	Personnel, medical, and similar files, disclosure of which constitutes a clearly unwarranted invasion of personal privacy
Section 20.63	Records or information compiled for law enforcement purposes
Section 20.64	National defense and foreign policy
Section 20.65	Internal personnel rules and practices
Section 20.66	Records exempted by other statutes
Section 20.67	Applicability of limitations on exemptions
Section 20.80	Data and information previously disclosed to the public
Section 20.81	Discretionary disclosure by the Commissioner
Section 20.82	Disclosure required by court order
Section 20.83	Disclosure to consultants, advisory committees, State and local government officials commissioned pursuant to 21 U
Section 20.84	Disclosure to other Federal government departments and agencies
Section 20.85	Disclosure in administrative or court proceedings
Section 20.86	Disclosure to Congress
Section 20.87	Communications with State and local government officials
Section 20.88	Communications with foreign government officials
Section 20.89	Disclosure to contractors
Section 20.90	Use of data or information for administrative or court enforcement action
Section 20.91	Applicability; cross-reference to other regulations
Section 20.100	Administrative enforcement records
Section 20.101	Court enforcement records
Section 20.102	Correspondence
Section 20.103	Summaries of oral discussions
Section 20.104	Testing and research conducted by or with funds provided by the Food and Drug Administration
Section 20.105	Studies and reports prepared by or with funds provided by the Food and Drug Administration
Section 20.106	Food and Drug Administration manuals
Section 20.107	Agreements between the Food and Drug Administration and other departments, agencies, and organizations
Section 20.108	Data and information obtained by contract
Section 20.109	Data and information about Food and Drug Administration employees
Section 20.110	Data and information submitted voluntarily to the Food and Drug Administration
Section 20.111	Voluntary drug experience reports submitted by physicians and hospitals
Section 20.112	Voluntary product defect reports
Section 20.113	Data and information submitted pursuant to cooperative quality assurance agreements
Section 20.114	Product codes for manufacturing or sales dates
Section 20.115	Drug and device listing information
Section 20.116	New drug information
Section 20.117	Advisory committee records
Section 20.118	Lists of names and addresses
Section 20.119	Records available in Food and Drug Administration Public Reading Rooms
Section 20.120	Scope